Bayesian Capital Management’s Amgen AMGN Stock Holding History

Bayesian Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-43,000	Closed	-$11.2M	–	595
2024 Q4	$11.2M	Buy	+43,000	New	+$12.8M	1.37%	2
2024 Q3	–	Sell	-12,022	Closed	-$3.76M	–	656
2024 Q2	$3.76M	Buy	12,022 +4,700	+64%	+$1.38M	0.43%	46
2024 Q1	$2.08M	Buy	+7,322	New	+$2.14M	0.2%	147
2023 Q4	–	Sell	-16,400	Closed	-$4.41M	–	728
2023 Q3	$4.41M	Sell	16,400 -2,000	-11%	-$499K	0.5%	45
2023 Q2	$4.09M	Buy	18,400 +13,500	+276%	+$3.13M	0.44%	37
2023 Q1	$1.18M	Buy	+4,900	New	+$1.2M	0.15%	208
2022 Q2	–	Sell	-4,300	Closed	-$1.04M	–	767
2022 Q1	$1.04M	Buy	+4,300	New	+$988K	0.16%	202
2020 Q1	–	Sell	-880	Closed	-$212K	–	765
2019 Q4	$212K	Buy	+880	New	+$194K	0.04%	521
2019 Q1	–	Sell	-9,900	Closed	-$1.93M	–	537
2018 Q4	$1.93M	Buy	+9,900	New	+$1.93M	0.39%	47
2018 Q2	–	Sell	-10,400	Closed	-$1.77M	–	585
2018 Q1	$1.77M	Buy	+10,400	New	+$1.91M	0.45%	31
2017 Q2	–	Sell	-14,423	Closed	-$2.37M	–	415
2017 Q1	$2.37M	Buy	+14,423	New	+$2.4M	1.12%	2

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bayesian Capital Management's AMGN Position: Q1 2025 in Review

Bayesian Capital Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 43,000 shares — an estimated $11.2M sold.

Bayesian Capital Management first reported a position in AMGN in Q1 2017 and held it in 11 quarters. The position peaked at $11.2M in Q4 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

Bayesian Capital Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
Bayesian Capital Management sold 43,000 Amgen shares in Q1 2025, an estimated $11.2M.
Bayesian Capital Management first reported a position in Amgen in Q1 2017 and held it in 11 quarters.
Bayesian Capital Management's Amgen position peaked at $11.2M in Q4 2024.
2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.